Alzheimer's Disease Drug Development: Research and Development Ecosystem - Image 1

£54.48

Cambridge University Press Alzheimer's Disease Drug Development: Research and Development Ecosystem

Name: Alzheimer's Disease Drug Development: Research and Development Ecosystem
Brand: Cambridge University Press
Price: 54.48 GBP
Availability: InStock

The Brain

This is the usual price. Wait for it to drop, or tell us your number.

£54 today · usual range £45–£90 · best ever £45

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 59 days · 59 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 59 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £90 (24 days, 40.7%)

Price range: £45 - £90

Price levels: 4 different prices over 59 days

Description

Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clinical trials, and funding and financing models. Also discussed is the critical role of advocacy fundraising for drug development. With the approval of aducanumab, the function of the ecosystem has become apparent. This is a definitive overview of how the ecosystem works in transferring an AD drug from its discovery in the laboratory through clinical trial testing to regulatory review and eventual marketing.

Product Specifications

Brand: Cambridge University Press
Format: hardcover
ASIN: 1108838669
Category: Books > Subjects > Science, Nature & Maths > Popular Science > Human Biology > The Brain
Domain: Amazon UK
Release Date: 31 March 2022
Listed Since: 14 June 2021

Barcode

No barcode data available

Cambridge University Press Alzheimer's Disease Drug Development: Research and Development Ecosystem

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Computational and Experimental Studies in Alzheimer's Disease

Biomarkers for Alzheimer’s Disease Drug Development: 2785 (Methods in Molecular Biology, 2785)

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Alzheimer’s Disease II: 24 (Topics in Medicinal Chemistry, 24)

Emerging Drugs and Targets for Alzheimer's Disease: Volume 2: Neuronal Plasticity (Drug Discovery Series)

Molecular Biology of Alzheimer's Disease: Genes and Mechanisms Involved in Amyloid Generation

Clinical Diagnosis and Management of Alzheimer's Disease

The End of Alzheimer's: The Brain and Beyond

Neuroprotection in Alzheimer's Disease

A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment

Alzheimer's Disease: Biology, Biophysics And Computational Models

Naturally Occurring Chemicals against Alzheimer’s Disease

The 2023-2028 Outlook for Alzheimer's Treatments in the United States

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Systems Biology of Alzheimer's Disease: 1303 (Methods in Molecular Biology, 1303)

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Biomarkers for Early Diagnosis of Alzheimer's Disease

Nutraceuticals for Alzheimer's Disease: A Promising Therapeutic Approach (Nutritional Neurosciences)

Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations